Genexine Inc.
SEC CIK 1834377 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RZLT | Rezolute, Inc. | 10% | 91.30M | $10.00M | — | 2 | 2019-04-26 | 2019-07-23 |
Most active insiders at RZLT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Evans Daron | CFO | $161.4K | — |
| 2 | Elam Nevan C | CEO, Dir | $50.9K | — |
| 3 | ROBERTS BRIAN KENNETH | Chief Medical Off | $47.6K | — |
| 4 | Karnawat Sunil Ratilal | Chief Commercial Off | $19.6K | — |
| 5 | Hogenhuis Wladimir | Dir | $9,548 | — |
| 6 | FAUCHET PHILIPPE | Dir | — | — |
| 7 | Harris Erik | Dir | — | — |
| 8 | Kim Young-Jin | Dir | — | — |
| 9 | KREHER NERISSA | Dir | — | — |
| 10 | Labrucherie Gil M | Dir | — | — |
Genexine Inc. made no open-market trades at RZLT in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-28 | 2019-07-23 | RZLT | Rezolute, Inc. | Genexine Inc. | 10% | P - Purchase | $0.29 | +34.48M | 91.30M | +61% | +$10.00M |
| D | 2021-07-28 | 2019-04-26 | RZLT | Rezolute, Inc. | Genexine Inc. | 10% | C - Cnv Deriv | — | +56.82M | 56.82M | New | — |
Purchase Sale Sale after option exercise All abbreviations